Immunovaccine Inc.

Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: Dorsey & Whitney LLP
Verified Company Profile 8/09/2017
Contact Info
  • 1344 Summer Street
  • Suite 412
  • Halifax, NS B3h 0A8
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: Toronto Stock Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Quarterly Report
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Nova Scotia, Canada
Year of Inc. 2007
Employees 30 a/o Dec 31, 2016
Company Officers/Contacts
Fred Ors CEO
Pierre Labbe CFO
Gabriela Rosu Chief Med. Officer
Brittany Davison Director, Fin.
Company Directors
Andrew Sheldon Chairman
Wade Dawe
Wayne Pisano
Albert Scardino
Alfred Smithers
Shermaine Tilley
Company Notes
  • Sponsored for OTCQX by Dorsey & Whitney LLP on 04/27/2015
  • Formerly=Immuno Vaccine Inc. until 4-2015
Service Providers
OTCQX Advisor
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202

Accounting/Auditing Firm
PricewaterhouseCoopers LLP
1601 Lower Water Street
Suite 400
Halifax, NS, B3J 3P6

Legal Counsel
McCarthy Tetrault LLP
700-1150 de Claire Fontaine
Quebec City, QC, G1R 5G4

Investor Relations Firm
Not Available
IMMVF Security Details
Share Structure
Market Value1 $121,526,590 a/o Oct 17, 2017
Authorized Shares Unlimited a/o Dec 31, 2016
Outstanding Shares 117,815,405 a/o Dec 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 85,840,478 a/o Dec 31, 2016
Par Value No Par Value
Transfer Agent(s)
Shareholders of Record Not Available
Non US Stock Exchange Listing
IMV - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 55,150 (1.1%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security